DHR-ICMR 2024-29 Action Plan Aims to Boost Indigenous Innovation, Tackle Critical Health Challenges: JP Nadda

DelhiThe Department of Health Research (DHR) -Indian Council of Medical Research (ICMR) announced the DHR-ICMR 2024-29 Action Plan for Viksit Bharat during the ICMR Governing Council Meeting that was presided by the Union Health & Family Welfare Minister, Shri JP Nadda. It is a comprehensive strategy aimed at transforming India’s health sector over the next five years. This ambitious plan focuses on indigenous innovation, advanced research, and global collaboration to build a self-reliant and robust healthcare system capable of addressing the nation’s most pressing health challenges.

Speaking on the occasion, Shri JP Nadda emphasized that “the DHR-ICMR 2024-29 Action Plan is a significant stride towards our vision of a Viksit Bharat”. He added, “By focusing on indigenous innovation, advanced research, and global collaboration, we are not only strengthening our healthcare infrastructure but also empowering our scientific community to lead on the world stage.”

Dr Rajiv Bahl, Secretary DHR & DG, ICMR, stated, “The DHR-ICMR 2024-29 Action Plan for Viksit Bharat represents a significant step towards achieving self-reliance in healthcare. By investing in indigenous technologies, addressing critical health challenges, and promoting global collaboration, we aim to transform the health landscape of India. This plan not only addresses current health issues but also prepares the nation for future challenges through innovation and capacity building.”

The DHR-ICMR 2024-29 Action Plan aims to transform India’s healthcare ecosystem by focusing on six key areas: promoting indigenous and affordable health technologies; providing solutions for difficult and resistant health problems such as anemia, antimicrobial resistance (AMR), non-communicable diseases (NCDs), child malnutrition, and climate change impacts; advancing digital health solutions; ensuring research evidence translation into action; enhancing technology-driven surveillance and accelerating development of medical countermeasures and elevating India’s global ranking in medical research thereby contributing significantly to medical advancements and improved health outcomes nationwide.

This comprehensive plan is expected to accelerate innovation, improve healthcare delivery, and position India as a leader in medical research and technology. It reflects the government’s commitment to enhancing public health and underscores the vital role of research and innovation in achieving sustainable development goals.

Read also: Health Minister JP Nadda addresses 77th session of Regional Committee of WHO South East Asia

Powered by WPeMatico

Health Ministry approves 13 additional BDS seats at Agartala Govt Dental College

Agartala- Recently the central government has allowed the Agartala Government Dental College to increase the number of seats in the Bachelor of Dental Surgery (BDS) course from 50 to 63 for the academic session 2025-26.

This decision was communicated recently through a letter which was issued by the Ministry of Health and Family Welfare.

The letter stated that “I am directed to convey the permission of the Central Government for increasing of the seats in BDS courses from 50 to 63 admissions for the academic year 2025-26”.

The government letter also mentioned that “the permission has been initially granted for one year and will be renewed in subsequent years based on the completion of annual targets. The process of renewal of permission in the original intake capacity will continue till such time the expansion of its facilities is completed”.

On this, Chief Minister Dr Manik Saha recently said through a social media post on Tuesday that “I extend my heartfelt gratitude to Prime Minister Narendra Modi Ji and Union Health Minister JP Nadda Ji for approving the increase of BDS seats from 50 to 63 at Agartala Government Dental College for the 2025-26 academic session”. He further added, “This will greatly help fulfil the aspirations of students in the state who wish to pursue dental education”.

Meanwhile, discrepancies, if any may be brought to be notice of the Dental Council of India and the Central Government, the letter further noted. The decision to increase BDS seats in Agartala Government Dental College will greatly increase the opportunities for students willing to pursue BDS courses in Tripura. 

Powered by WPeMatico

Amrita Hospital Launches Third Phase of ‘Dengue All’ Vaccine Trial

Kochi: Amrita Hospital has commenced the third phase of testing for the ‘Dengue All’ vaccine, marking a significant milestone in the battle against dengue fever. This trial is the first of its kind to progress to this stage in India. 

According to a UNI report, the trial is being conducted at the Amrita Urban Health Centre in Kaloor under the leadership of Amrita Hospital’s Community Medicine, Microbiology, and General Medicine departments.

The Indian Council of Medical Research (ICMR) and Panacea Biotec are overseeing the study, which includes 10,335 participants from 19 locations in India.

Also Read:Doctors at Amrita Hospital conduct first robot-assisted surgery for rare colon tumour

“All types of the Dengue are present in India, so people who have had dengue can be infected again,” explains Dr. Mary Jo, Associate Professor of Community Medicine. “Our study aims to develop a vaccine that is effective against all strains of dengue,” she said.

According to the WHO, India accounts for one-third of the world’s dengue cases, and most cases are asymptomatic. Children and young adults are more likely to experience severe illness. Earlier trial phases of ‘Dengue All’ have shown that the vaccine works against all known dengue strains.

Medical Dialogues team had earlier reported that the Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec. The first participant in this trial was vaccinated at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak. 

Commenting on this milestone, Union Minister of Health & Family Welfare, Shri J.P. Nadda, said, “The initiation of this Phase 3 clinical trial for India’s first indigenous dengue vaccine marks a critical advancement in our fight against dengue. It reflects our commitment to protecting our citizens from this pervasive disease and underscores India’s capabilities in vaccine research and development. Through this collaboration between ICMR and Panacea Biotec, we are not only taking a step towards ensuring the health and well-being of our people but also reinforcing our vision of Atmanirbhar Bharat in the healthcare sector.”

Also Read:Amrita Hospital Faridabad, IIT Hyderabad join hands to develop robot-assisted ultrasound system for cancer patients

Powered by WPeMatico

Fact Check: Can Black Pepper be used for Cholera and Syphilis?

A Pinterest post claims that black pepper can be used for Cholera and Syphilis. The claim is False.

Claim

A Pinterest post titled, ” Black Pepper Health Benefits”, claims that, “black pepper can be used for cholera and syphilis.” In the post, the user Deena Barger states, ” Black pepper, one of the most ancient and prolifically traded of spices, having been employed for culinary and medicinal use, such as for, colds, nasal congestion, diarrhoea, anaemia, improve blood circulation, heart and lung tonic, halitosis and relieve toothache, indigestion remedy, anti-inflammatory, cholera and syphilis, mild to moderate stomach complaints, hoarseness of voice and sore throat, gingivitis, minor cuts and bruises, rinse for wounds, helps to prevent or delay food spoilage.”

Along with other claims, the post claims that black pepper can be used for cholera and syphilis.

The post can be accessed here.

Fact Check

The claim is False. While having antibacterial, antioxidant and antidiarrhoeal properties, black pepper exhibits multiple benefits but it is not a medically recommended therapy for the management of cholera and syphilis.

What is Cholera?

As defined by the WHO (World Health Organization), cholera is an acute diarrhoeal infection caused by the ingestion of food or water contaminated with the bacterium Vibrio cholerae. Cholera remains a global threat to public health and an indicator of inequity and lack of social development.

Symptoms of cholera include severe acute watery diarrhoea, and in serious cases of the disease, it can kill within hours if left untreated.

Most people who get infected with cholera bacteria don’t show any symptoms, but they still carry the bacteria in their stool for 1 to 10 days, spreading it to others. Most of those who do show symptoms have mild to moderate signs. It usually takes 12 hours to 5 days for symptoms to appear. However, a small number of people can develop severe watery diarrhea that causes serious dehydration, which can be fatal if not treated quickly.

 

Dr Tilottama, MBBS, MD (Preventive Medicine) Consultant Medicine, Sanjeevan Hospital, talked about the main causes and transmission methods of cholera. She explained, “Cholera is a highly infectious disease primarily caused by the bacterium Vibrio cholerae, which spreads through the ingestion of contaminated food or water. The main sources of contamination include unsafe drinking water, poor sanitation, and food that’s been improperly handled. People living in areas with inadequate water treatment, crowded settings, or during humanitarian crises are at the highest risk. Cholera can lead to severe, watery diarrhoea, which, if untreated, can result in rapid dehydration and death within hours.”

Syphilis and Its Symptoms

Syphilis is a bacterial sexually transmitted infection (STI) caused by Treponema pallidum which results in substantial morbidity and mortality, and it is curable. Syphilis is transmitted through sexual contact with the infectious lesions, via blood transfusion or from a pregnant woman to her fetus. Syphilis in pregnancy may lead to stillbirth, newborn death and babies born with syphilis (congenital syphilis).

Many people with syphilis do not notice any symptoms. They can also go unnoticed by healthcare providers. Untreated, syphilis lasts many years and has several stages.

Medical Dialogues Fact Check Team spoke to Dr Swati Rajagopal, (MBBS, MD (Medicine), MMed (Infectious Diseases), PGDIP (Infectious Diseases and Travel Medicine) is a Consultant (Infectious Disease & Travel Medicine) at Aster CMI Hospital, Bengaluru about early symptoms of syphilis and diagnosis. She said “Syphilis progresses through several stages, each with distinct symptoms. In primary syphilis, a round, painless sore (chancre) appears, typically on the genitals or anus, lasting about 21 days. It often goes unnoticed and heals on its own within a week or two, advancing to secondary syphilis if untreated. This stage features a non-itchy rash, especially on the palms and soles, along with white or grey lesions in moist areas like the anus or labia. The latent stage has no symptoms but can progress to tertiary syphilis after years, potentially causing serious issues like heart and brain damage. Early diagnosis through blood tests is crucial for effective treatment.”

Health Benefits of Black Pepper

Black pepper (Piper Nigrum) belongs to the Piperaceae family, with over 1,000 species mainly found in tropical and subtropical areas. The main active ingredient in black pepper is piperine, which also contains volatile oils, oleoresins, and several other natural compounds.

Black pepper has antioxidant, anti-inflammatory, and antimicrobial properties, which can help protect the body from damage, reduce inflammation, and fight certain germs. It may also help prevent or relieve digestive problems by boosting the production of hydrochloric acid in the stomach. Furthermore, black pepper has diaphoretic effects, meaning it can increase sweating, which helps the body cool down or flush out toxins. It also has diuretic properties, which promotes urination, helping to remove excess fluid and waste from the body. Furthermore, black pepper prevents the breakdown of fats in the body (known as lipid peroxidation) and boosts the body’s antioxidant levels, which help fight harmful free radicals.

Can Black Pepper be used for Cholera and Syphilis?

Black pepper exhibits a range of medicinal properties, including antibacterial, anti-inflammatory, and antioxidant effects, which have been supported by various studies. While it has demonstrated effectiveness in managing conditions like diarrhoea by reducing chloride and water secretion in the intestines, there is no credible scientific evidence to support the claim that black pepper can be used for cholera or syphilis.

Some studies investigated black pepper’s potential role in combating cholera. A study in the International Journal of Enteric Pathogens highlighted that black pepper has strong antibacterial properties, suggesting it could be used as an inhibitory extract against S. aureus and V. cholerae in the food industry.

Yet another study by Pongkorpsakol et al. evaluated the efficacy of a potent compound of an antidiarrhoeal formulation (black pepper extract) used in folk medicine in some countries such as Thailand and found that piperine(an active ingredient of black pepper) can limit excessive chloride and water secretion in the intestines, which helps reduce diarrhoea. However, none of the scientific evidence support that black pepper should be used for cholera

Similarly, there is no evidence existing that black pepper can be used in syphilis. A review article in Medicine in Drug Discovery highlighted that Decoction (seeds) of Piper guineense Linn. (which belongs to the same family as black pepper) has potential therapeutic effects, suggesting it could be used for syphilis, as well as conditions like fungal infections, asthma, respiratory diseases, and female infertility. However, even this study could not categorically support the individual claim that black pepper should be used in syphilis. 

Dr Swati Rajagopal, (MBBS, MD (Medicine), MMed (Infectious Diseases), PGDIP (Infectious Diseases and Travel Medicine) is a Consultant (Infectious Disease & Travel Medicine) at Aster CMI Hospital, Bengaluru told Health Dialogues that, “Black pepper is well-known for its culinary uses and potential health benefits, but it is not a treatment for cholera or syphilis. There is no medical evidence supporting its effectiveness against these diseases. Cholera requires rapid rehydration therapy and antibiotic intervention to manage severe fluid loss, while syphilis must be treated with prescribed antibiotics to stop the infection. Individuals should seek proper medical advice and not rely on remedies like black pepper as cures for these serious conditions.”

Adding to this Dr Tilottama, MBBS, MD (Preventive Medicine) Consultant Medicine, Sanjeevan Hospital, said, While black pepper is often recognized for its antimicrobial and antioxidant properties, it is not a substitute for medical treatment when dealing with serious diseases like cholera or syphilis. Cholera requires urgent rehydration and antibiotics to address the bacterial infection, while syphilis needs a specific antibiotic regimen to manage effectively. Relying on black pepper or any other home remedy in these cases can delay proper treatment, potentially leading to severe complications.

Medical Dialogues Final Take

Black pepper is recognized for its broad medicinal properties, including its roles as an antibacterial agent and an antidiarrheal by managing fluid secretion in the intestines. It has shown potential in certain contexts, such as food safety and in alleviating digestive issues. Despite its diverse health benefits and culinary value, it is important to note that black pepper is not suitable for treating severe infections like cholera or syphilis, which require specialized medical intervention. Hence the claim that Black Pepper can be used for Cholera and Syphilis is False.

Powered by WPeMatico

Union Health Minister Nadda unveils Five DHR-ICMR Health Research Initiatives

Delhi: Union Health Minister, Shri Jagat Prakash Nadda recently launched five DHR-ICMR health research initiatives planned under the 100 days agenda. These initiatives aim to propel India to the forefront of global health research and innovation, aligning with the nation’s vision of a Viksit Bharat.

Addressing the occasion, Shri JP Nadda remarked, “These groundbreaking initiatives exemplify our commitment to a healthier and more self-reliant India. By fostering indigenous innovation and investing in advanced research, we are equipping our nation to tackle pressing health challenges effectively.”

Dr Rajiv Bahl, Secretary DHR & DG ICMR said, “Initiatives like the ‘First in the World’ Challenge will empower our scientists and innovators to develop cutting-edge technologies that can benefit not just India but the entire world. We are committed to fostering an environment where research thrives, ultimately leading to improved health outcomes and a stronger global standing in medical research for our nation.”

One of the key initiatives launched is the “First in the World” Challenge, inspired by the success of Chandrayaan-3. This high-risk, high-reward research and development scheme is designed to foster the creation of health technologies that are unprecedented globally. The program will fund projects at various stages from proof of concept design to prototype and final product development.

Additionally, under the Pradhan Mantri – Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), ICMR is upgrading existing Viral Research & Diagnostic Laboratories (VRDLs) to Infectious Disease Research and Diagnostic Laboratories (IRDLs). This enhancement includes bacteriology, mycology, and parasitology, expanding diagnostic capabilities beyond virology. These laboratories will strengthen India’s capacity for comprehensive surveillance and rapid response to infectious diseases.

ICMR also launched the ICMR Data Repository, a centralized, secure, and accessible platform of high-quality datasets, ensuring data integrity and privacy. The UNNATI Initiative (Upgrading Norms for Nutrition, Growth, and Development Assessment of Indian Children) aims to establish India-specific growth and development standards for children, addressing limitations of existing WHO benchmarks.

Moreover, ICMR is initiating efforts to develop drugs for rare diseases, focusing on affordable and effective therapies for conditions such as Gaucher Disease, Sickle Cell Disease, and others. Ongoing projects range from clinical trials to animal studies and design phases, aiming to reduce dependence on imported treatments and improve accessibility for patients in India.

Powered by WPeMatico

Apollo Hospitals unveils first-of-its-kind Hand Clinic in Ahmedabad

Ahmedabad: Apollo Hospitals has launched the first-of-its-kind comprehensive Hand Clinic in Ahmedabad that will provide multidisciplinary care for all hand-related issues. This innovative clinic brings together a team of experts, including plastic surgeons, orthopaedic surgeons, rheumatologists and physiotherapists, to address a wide range of conditions affecting the hands.
From congenital conditions such as fused fingers or missing digits in young children to injuries sustained by adults and arthritis in senior citizens, the Apollo Hand Clinic is designed to offer complete solutions for patients of all ages.
Dr Aniket Dave, Consultant Plastic Surgeon and Reconstructive Surgery, at Apollo Hospitals Ahmedabad, said, “The Hand Clinic is the first of its kind in Ahmedabad and a one-stop-shop for all medical and surgical problems related to hands. We aim to provide complete solutions to patients.”
Dr Vishnu Sharma, Senior Consultant, Rheumatology, at Apollo Hospitals Ahmedabad, said, “The launch of this pioneering Hand Clinic showcases our commitment to delivering holistic care. Our multidisciplinary team will ensure that every patient receives personalised treatment.”
Along with treating complex hand injuries and chronic conditions, the clinic, located at Apollo Hospital in Bhat, Gandhinagar, will also focus on rehabilitation, ensuring patients regain optimal function and mobility in their hands.
The other specialists at the Hand Clinic include Dr. Neil Rohra, Consultant Orthopaedics, Dr. Pratyusha Priyadarshini, Consultant Plastic and Reconstructive Surgeon, and Dr Nikunj Dadhaniya, Consultant Rheumatologist.

Powered by WPeMatico

What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?

Prostate cancer is Australia’s most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85.

Powered by WPeMatico

How asbestos exposure continues to be a dire health risk in the UK, 25 years after it was banned

Asbestos may have been banned from use in the UK since 1999, but the hazardous material continues to pose a serious danger to the population.

Powered by WPeMatico

Trial assesses antibody therapy for chronic active antibody-mediated kidney transplant rejection

Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant recipients’ kidney function in a Phase II trial. Investigators now have data from a Phase III trial with clazakizumab.

Powered by WPeMatico

South Africa has amended its research guidelines to allow for heritable human genome editing

A little-noticed change to South Africa’s national health research guidelines, published in May of this year, has put the country on an ethical precipice. The newly added language appears to position the country as the first to explicitly permit the use of genome editing to create genetically modified children.

Powered by WPeMatico